Citadel Investment Advisory’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
AACR
Citadel Investment Advisory's JNJ Position: Q2 2026 in Review
Citadel Investment Advisory increased its Johnson & Johnson (JNJ) stake by 0% in Q2 2026, buying an estimated $233 and bringing the position to 23,054 shares worth $5.86M. The position accounts for 2.66% of the portfolio, ranked #7.
Citadel Investment Advisory first reported a position in JNJ in Q4 2020 and has held it in 23 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Citadel Investment Advisory held 23,054 shares of Johnson & Johnson worth $5.86M as of Q2 2026.
- Citadel Investment Advisory bought 1 Johnson & Johnson share in Q2 2026, an estimated $233.
- Johnson & Johnson made up 2.66% of Citadel Investment Advisory's portfolio in Q2 2026, its #7 holding.
- Citadel Investment Advisory first reported a position in Johnson & Johnson in Q4 2020 and has held it in 23 quarters since.
- 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Citadel Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.